NUTRALIFE BIOSCIENCES, INC Quarterly Debt-to-equity in % from Q3 2015 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nutralife Biosciences, Inc quarterly Debt-to-equity history and growth rate from Q3 2015 to Q3 2022.
  • Nutralife Biosciences, Inc Debt-to-equity for the quarter ending September 30, 2022 was -459 %, a 101% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -459 -38.2K -101% Sep 30, 2022
Q2 2022 -595 -3.34K -122% Jun 30, 2022
Q1 2022 -909 -2.01K -183% Mar 31, 2022
Q4 2021 -2.02K -2.68K -408% Dec 31, 2021
Q3 2021 37.8K +37.4K +9658% Sep 30, 2021
Q2 2021 2.74K +2.52K +1137% Jun 30, 2021
Q1 2021 1.1K +953 +643% Mar 31, 2021
Q4 2020 656 +550 +521% Dec 31, 2020
Q3 2020 387 +294 +315% Sep 30, 2020
Q2 2020 221 +133 +151% Jun 30, 2020
Q1 2020 148 Mar 31, 2020
Q4 2019 106 Dec 31, 2019
Q3 2019 93.3 Sep 30, 2019
Q2 2019 88.4 Jun 30, 2019
Q3 2015 -181 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.